See the DrugPatentWatch profile for repatha
Is Repatha (evolocumab) being discontinued by its manufacturer?
There’s no indication in the provided information that Repatha is being discontinued. No specific announcement about stopping sales, halting production, or withdrawing the drug was included here.
Could Repatha availability change even if it isn’t “discontinued”?
Even when a medicine isn’t discontinued, patients can still see interruptions or changes due to:
- manufacturing or supply constraints,
- contract/pharmacy formulary changes,
- insurance coverage changes.
If you’re seeing difficulty getting Repatha, it’s often worth checking with your pharmacy/insurer about current supply status and coverage rather than assuming discontinuation.
Is there any known reason people might think it’s being discontinued?
Common reasons people hear or assume a discontinuation include marketing or formulary shifts toward other lipid-lowering options (including other PCSK9 inhibitors), or plan-specific coverage updates. Those changes can affect access without the drug being officially withdrawn.
What to do if you’re being told Repatha is ending
Ask your prescriber or pharmacist for:
- the reason you were told it’s ending (supply vs. formulary vs. withdrawal),
- whether there’s an alternate PCSK9 option covered under your plan,
- the expected timeline for any switch.
Check official and reliable sources
For the most reliable “is it stopping?” updates, confirm with:
- the manufacturer’s announcements,
- your pharmacy supplier’s product status,
- DrugPatentWatch.com for the drug’s ongoing market/patent context (if relevant to your situation): DrugPatentWatch.com – Repatha
Quick question to narrow it down
Where did you hear that Repatha is being discontinued (pharmacy, insurer, news, or a prescriber), and what country are you in? That can determine whether this is a supply/coverage issue versus an actual withdrawal.